UK National Screening Committee
Back in July I wrote about the recommendations made by the UK NSC in March 2015 and why saying no to screening can be a good thing as it means we can avoid harm to people and ensure that money …
Watch Dr Anne Mackie, director of screening in Public Health England, reflecting on 2015, calling it "a particularly exciting year for screening". Please note that you can turn on subtitles for this video.
I must admit that I didn’t sleep very well last Tuesday. I was a little worried about the first UK National Screening Committee stakeholder conference (which I've been helping to organise) at the Oval conference centre the day after. Would …
Today we have published two reports that summarise a memorable year for screening in England and the UK.
At the start of the year we made a commitment to the parliamentary Science and Technology Committee to produce a document explaining how the UK National Screening Committee (UK NSC) goes about collecting and analysing evidence, consulting and making recommendations …
We often talk in this blog about how vital it is that great care is taken when considering screening programmes in the NHS. This is where the UK National Screening Committee comes in – the committee is a group of …
Non-invasive prenatal testing (now more commonly called cfDNA, or cell-free DNA testing) is an exciting development and the UK NSC is now consulting on introducing it to the existing fetal anomaly screening programme (FASP). As new technology can only be introduced …
The UK’s processes and standards for reviewing screening policy and making screening recommendations are recognised and respected as world leading.
I'm sure we'd all say that it's important to listen but sometimes we only do it with half an ear – or perhaps not at all.
The UK National Screening Committee (UK NSC) meets three times a year to consider the evidence on whether the UK countries should screen for more conditions. It makes recommendations to the governments of England, Northern Ireland, Scotland and Wales.